{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:27:34Z","timestamp":1788280054094,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273599"],"award-info":[{"award-number":["81273599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00380-019-01478-y","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T05:02:48Z","timestamp":1564376568000},"page":"153-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1\u20137)-MAS axis and coronary heart disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Xiaomin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-5184","authenticated-orcid":false,"given":"Huimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"4","key":"1478_CR1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/cphy.c120002","volume":"2","author":"MC Chappell","year":"2012","unstructured":"Chappell MC (2012) Nonclassical renin-angiotensin system and renal function. Compr Physiol 2(4):2733\u20132752","journal-title":"Compr Physiol"},{"issue":"8","key":"1478_CR2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/1440-1681.12069","volume":"40","author":"SK Patel","year":"2013","unstructured":"Patel SK, Velkoska E, Burrell LM (2013) Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? Clin Exp Pharmacol Physiol 40(8):551\u2013559","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1478_CR3","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292(1):C82\u201397","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"1478_CR4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S (2000) a novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res 87(5):e1\u2013e9","journal-title":"Circ Res"},{"issue":"43","key":"1478_CR5","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"Sarah R. Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238\u201333243","journal-title":"Journal of Biological Chemistry"},{"issue":"14","key":"1478_CR6","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"Robson A. S. Santos","year":"2003","unstructured":"Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100(14):8258\u20138263","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"1478_CR7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","volume":"16","author":"J Varagic","year":"2014","unstructured":"Varagic J, Ahmad S, Nagata S, Ferrario CM (2014) ACE2: angiotensin II\/angiotensin-(1\u20137) balance in cardiac and renal injury. Curr Hypertens Rep 16(3):420","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"1478_CR8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","volume":"103","author":"C Mercure","year":"2008","unstructured":"Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL (2008) Angiotensin(1\u20137) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103(11):1319\u20131326","journal-title":"Circ Res"},{"issue":"7","key":"1478_CR9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","volume":"126","author":"VB Patel","year":"2014","unstructured":"Patel VB, Parajuli N, Oudit GY (2014) Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin Sci (Lond) 126(7):471\u2013482","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"1478_CR10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/HJH.0b013e328335d291","volume":"28","author":"MP Ocaranza","year":"2010","unstructured":"Ocaranza MP, Lavandero S, Jalil JE, Moya J, Pinto M, Novoa U, Apablaza F, Gonzalez L, Hernandez C, Varas M, Lopez R, Godoy I, Verdejo H, Chiong M (2010) Angiotensin-(1\u20139) regulates cardiac hypertrophy in vivo and in vitro. J Hypertens 28(5):1054\u20131064","journal-title":"J Hypertens"},{"issue":"2","key":"1478_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","volume":"59","author":"M Flores-Munoz","year":"2012","unstructured":"Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, Nicklin SA (2012) Angiotensin-(1\u20139) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension 59(2):300\u2013307","journal-title":"Hypertension"},{"issue":"3","key":"1478_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.2357","volume":"215","author":"JC Sluimer","year":"2008","unstructured":"Sluimer JC, Gasc JM, Hamming I, van Goor H, Michaud A, van den Akker LH, Jutten B, Cleutjens J, Bijnens AP, Corvol P, Daemen MJ, Heeneman S (2008) Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J Pathol 215(3):273\u2013279","journal-title":"J Pathol"},{"issue":"2","key":"1478_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1470320314542829","volume":"16","author":"YH Zhang","year":"2015","unstructured":"Zhang YH, Hao QQ, Wang XY, Chen X, Wang N, Zhu L, Li SY, Yu QT, Dong B (2015) ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis. J Renin Angiotensin Aldosterone Syst 16(2):292\u2013300","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3\u20134","key":"1478_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00011-015-0805-1","volume":"64","author":"YH Zhang","year":"2015","unstructured":"Zhang YH, Zhang YH, Dong XF, Hao QQ, Zhou XM, Yu QT, Li SY, Chen X, Tengbeh AF, Dong B, Zhang Y (2015) ACE2 and Ang-(1\u20137) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response. Inflamm Res 64(3\u20134):253\u2013260","journal-title":"Inflamm Res"},{"issue":"36","key":"1478_CR15","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1073\/pnas.1001253107","volume":"107","author":"C Zhang","year":"2010","unstructured":"Zhang C, Zhao YX, Zhang YH, Zhu L, Deng BP, Zhou ZL, Li SY, Lu XT, Song LL, Lei XM, Tang WB, Wang N, Pan CM, Song HD, Liu CX, Dong B, Zhang Y, Cao Y (2010) Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc Natl Acad Sci USA 107(36):15886\u201315891","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1478_CR16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/ATVBAHA.108.164715","volume":"28","author":"B Dong","year":"2008","unstructured":"Dong B, Zhang C, Feng JB, Zhao YX, Li SY, Yang YP, Dong QL, Deng BP, Zhu L, Yu QT, Liu CX, Liu B, Pan CM, Song HD, Zhang MX, Zhang Y (2008) Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 28(7):1270\u20131276","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"1478_CR17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","volume":"107","author":"MC Thomas","year":"2010","unstructured":"Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C (2010) Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 107(7):888\u2013897","journal-title":"Circ Res"},{"key":"1478_CR18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ijcard.2015.03.059","volume":"184","author":"J Yang","year":"2015","unstructured":"Yang J, Yang X, Meng X, Dong M, Guo T, Kong J, Zhang K, Zhang Y, Zhang C (2015) Endogenous activated angiotensin-(1\u20137) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice. Int J Cardiol 184:645\u2013652","journal-title":"Int J Cardiol"},{"issue":"8","key":"1478_CR19","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","volume":"30","author":"S Tesanovic","year":"2010","unstructured":"Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE (2010) Vasoprotective and atheroprotective effects of angiotensin (1\u20137) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30(8):1606\u20131613","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"1478_CR20","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","volume":"33","author":"JM Yang","year":"2013","unstructured":"Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP, Li JJ, Wang XP, Zhang K, Gao F, Zhao XQ, Zhang MX, Zhang Y, Zhang C (2013) Angiotensin-(1\u20137) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol 33(8):1978\u20131985","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1478_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/heartjnl-2012-302482","volume":"100","author":"SJ Head","year":"2014","unstructured":"Head SJ, Farooq V, Serruys PW, Kappetein AP (2014) The SYNTAX score and its clinical implications. Heart 100(2):169\u2013177","journal-title":"Heart"},{"issue":"Suppl 2","key":"1478_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000066410","volume":"11","author":"NA Abdella","year":"2002","unstructured":"Abdella NA (2002) Controversies in management of diabetes in patients with coronary heart disease. Med Princ Pract 11(Suppl 2):69\u201374","journal-title":"Med Princ Pract"},{"issue":"6","key":"1478_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/hr.2010.43","volume":"33","author":"M Akishita","year":"2010","unstructured":"Akishita M, Fukai S, Hashimoto M, Kameyama Y, Nomura K, Nakamura T, Ogawa S, Iijima K, Eto M, Ouchi Y (2010) Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. Hypertens Res 33(6):587\u2013591","journal-title":"Hypertens Res"},{"key":"1478_CR24","unstructured":"Authors\/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541\u20132619"},{"issue":"25","key":"1478_CR25","first-page":"e344","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, Members AATF (2014) 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 130(25):e344\u2013426","journal-title":"Circulation"},{"issue":"2","key":"1478_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","volume":"30","author":"Aino Soro-Paavonen","year":"2012","unstructured":"Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thomas MC, Groop PH, FinnDiane Study G (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 30(2):375\u2013383","journal-title":"Journal of Hypertension"},{"issue":"9","key":"1478_CR27","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/ndt\/gft038","volume":"28","author":"MA Roberts","year":"2013","unstructured":"Roberts MA, Velkoska E, Ierino FL, Burrell LM (2013) Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease. Nephrol Dial Transpl 28(9):2287\u20132294","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"1478_CR28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.110.153668","volume":"56","author":"JC Sullivan","year":"2010","unstructured":"Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA (2010) Angiotensin (1\u20137) receptor antagonism equalizes angiotensin II\u2013induced hypertension in male and female spontaneously hypertensive rats. Hypertension 56(4):658\u2013666","journal-title":"Hypertension"},{"issue":"10","key":"1478_CR29","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00677.2013","volume":"306","author":"MA Zimmerman","year":"2014","unstructured":"Zimmerman MA, Harris RA, Sullivan JC (2014) Female spontaneously hypertensive rats are more dependent on ANG (1\u20137) to mediate effects of low-dose AT1 receptor blockade than males. Am J Physiol Renal Physiol 306(10):F1136\u20131142","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"1478_CR30","doi-asserted-by":"crossref","first-page":"H1171","DOI":"10.1152\/ajpheart.00897.2014","volume":"308","author":"JC Sullivan","year":"2015","unstructured":"Sullivan JC, Rodriguez-Miguelez P, Zimmerman MA, Harris RA (2015) Differences in angiotensin (1\u20137) between men and women. Am J Physiol Heart Circ Physiol 308(9):H1171\u20131176","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1478_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3317\/jraas.2006.015","volume":"7","author":"A Reyes-Engel","year":"2006","unstructured":"Reyes-Engel A, Morcillo L, Aranda FJ, Ruiz M, Gaitan MJ, Mayor-Olea A, Aranda P, Ferrario CM (2006) Influence of gender and genetic variability on plasma angiotensin peptides. J Renin Angiotensin Aldosterone Syst 7(2):92\u201397","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"14","key":"1478_CR32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/1535370217718808","volume":"242","author":"A Bukowska","year":"2017","unstructured":"Bukowska A, Spiller L, Wolke C, Lendeckel U, Weinert S, Hoffmann J, Bornfleth P, Kutschka I, Gardemann A, Isermann B, Goette A (2017) Protective regulation of the ACE2\/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood) 242(14):1412\u20131423","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"1478_CR33","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.peptides.2009.09.005","volume":"30","author":"V Shenoy","year":"2009","unstructured":"Shenoy V, Grobe JL, Qi Y, Ferreira AJ, Fraga-Silva RA, Collamat G, Bruce E, Katovich MJ (2009) 17\u03b2-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 30(12):2309\u20132315","journal-title":"Peptides"},{"key":"1478_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.11.004","volume":"422","author":"A Mompe\u00f3n","year":"2016","unstructured":"Mompe\u00f3n A, L\u00e1zaro-Franco M, Bueno-Bet\u00ed C, P\u00e9rez-Cremades D, Vidal-G\u00f3mez X, Monsalve E, Gironacci MM, Hermenegildo C, Novella S (2016) Estradiol, acting through ER\u03b1, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1\u20137 production. Mol Cell Endocrinol 422:1\u20138","journal-title":"Mol Cell Endocrinol"},{"issue":"3 Suppl","key":"1478_CR35","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jacc.2005.01.072","volume":"47","author":"LJ Shaw","year":"2006","unstructured":"Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, Investigators W (2006) Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47(3 Suppl):S4\u2013S20","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1478_CR36","doi-asserted-by":"crossref","first-page":"e87845","DOI":"10.1371\/journal.pone.0087845","volume":"9","author":"K Uri","year":"2014","unstructured":"Uri K, Fagyas M, Manyine Siket I, Kertesz A, Csanadi Z, Sandorfi G, Clemens M, Fedor R, Papp Z, Edes I, Toth A, Lizanecz E (2014) New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS ONE 9(4):e87845","journal-title":"PLoS ONE"},{"issue":"9","key":"1478_CR37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","volume":"52","author":"S Epelman","year":"2008","unstructured":"Epelman S, Tang WHW, Chen SY, Van Lente F, Francis GS, Sen S (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure. J Am Coll Cardiol 52(9):750\u2013754","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1478_CR38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","volume":"48","author":"MP Ocaranza","year":"2006","unstructured":"Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, Roman M, Ramirez C, Copaja M, Diaz-Araya G, Castro P, Lavandero S (2006) Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48(4):572\u2013578","journal-title":"Hypertension"},{"issue":"4","key":"1478_CR39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/eurheartj\/ehi043","volume":"26","author":"LS Zisman","year":"2005","unstructured":"Zisman LS (2005) ACE and ACE2: a tale of two enzymes. Eur Heart J 26(4):322\u2013324","journal-title":"Eur Heart J"},{"issue":"3","key":"1478_CR40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","volume":"51","author":"S Der Sarkissian","year":"2008","unstructured":"Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, Raizada MK (2008) Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 51(3):712\u2013718","journal-title":"Hypertension"},{"issue":"1\u20132","key":"1478_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000365093","volume":"94","author":"J Flores-Monroy","year":"2014","unstructured":"Flores-Monroy J, Ferrario CM, Valencia-Hernandez I, Hernandez-Campos ME, Martinez-Aguilar L (2014) Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Pharmacology 94(1\u20132):21\u201328","journal-title":"Pharmacology"},{"issue":"11","key":"1478_CR42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","volume":"123","author":"LJ Burchill","year":"2012","unstructured":"Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM (2012) Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci (Lond) 123(11):649\u2013658","journal-title":"Clin Sci (Lond)"},{"issue":"Suppl 1","key":"1478_CR43","doi-asserted-by":"crossref","first-page":"P142","DOI":"10.1186\/1532-429X-13-S1-P142","volume":"13","author":"JT Ortiz P\u00e9rez","year":"2011","unstructured":"Ortiz P\u00e9rez JT, Riera M, Genover X, De Caralt T, Perea R, Pascual J, Romeo M (2011) Serum ACE2 activity correlates with infarct size and left ventricular dysfunction during acute myocardial infarction. J Cardiovasc Magn Reson 13(Suppl 1):P142","journal-title":"J Cardiovasc Magn Reson"},{"key":"1478_CR44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1475-2840-12-151","volume":"12","author":"W Liu","year":"2013","unstructured":"Liu W, Zhou X, Yu F, Hu J, Hu W (2013) Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence. Cardiovasc Diabetol 12:151","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1478_CR45","doi-asserted-by":"crossref","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM (2018) Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE 13(6):e0198144","journal-title":"PLoS ONE"},{"issue":"2","key":"1478_CR46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.semtcvs.2011.07.006","volume":"23","author":"JS Lawton","year":"2011","unstructured":"Lawton JS (2011) Sex and gender differences in coronary artery disease. Semin Thorac Cardiovasc Surg 23(2):126\u2013130","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"2","key":"1478_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.gme.0000174095.49029.56","volume":"13","author":"H Gylling","year":"2006","unstructured":"Gylling H, Rajaratnam RA, Vartiainen E, Puska P, Miettinen TA (2006) Changes in serum level and metabolism of cholesterol with plant stanol esters in postmenopausal women with and without coronary artery disease. Menopause 13(2):286\u2013293","journal-title":"Menopause"},{"issue":"34","key":"1478_CR48","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280(34):30113\u201330119","journal-title":"J Biol Chem"},{"issue":"5","key":"1478_CR49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","volume":"204","author":"AT Lely","year":"2004","unstructured":"Lely AT, Hamming I, van Goor H, Navis GJ (2004) Renal ACE2 expression in human kidney disease. J Pathol 204(5):587\u2013593","journal-title":"J Pathol"},{"issue":"9","key":"1478_CR50","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/ndt\/gft240","volume":"28","author":"J Wysocki","year":"2013","unstructured":"Wysocki J, Batlle D (2013) Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity? Nephrol Dial Transpl 28(9):2200\u20132202","journal-title":"Nephrol Dial Transpl"},{"key":"1478_CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2015.06.018","volume":"101","author":"F Westermeier","year":"2015","unstructured":"Westermeier F, Bustamante M, Pavez M, Garcia L, Chiong M, Ocaranza MP, Lavandero S (2015) Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1\u20137) and angiotensin-(1\u20139). Pharmacol Res 101:41\u201355","journal-title":"Pharmacol Res"},{"issue":"2","key":"1478_CR52","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3892\/mmr.2017.6848","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, He W, Guo L, Zhang Y, Li H, Han S, Shen D (2017) The ACE2-Ang (1\u20137)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Mol Med Rep 16(2):1973\u20131981","journal-title":"Mol Med Rep"},{"issue":"1","key":"1478_CR53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ (2018) The ACE2\/angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137). Physiol Rev 98(1):505\u2013553","journal-title":"Physiol Rev"},{"key":"1478_CR54","doi-asserted-by":"publisher","DOI":"10.1177\/1470320316659618","author":"W Li","year":"2016","unstructured":"Li W, Li J, Hao P, Chen W, Meng X, Li H, Zhang Y, Zhang C, Yang J (2016) Imbalance between angiotensin II and angiotensin-(1\u20137) in human coronary atherosclerosis. J Renin Angiotensin Aldosterone Syst. https:\/\/doi.org\/10.1177\/1470320316659618","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01478-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01478-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T15:41:48Z","timestamp":1664034108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01478-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01478-y","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare all human studies have been approved by the appropriate ethics committee and have, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with animals performed by any of the authors. All persons gave their informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}